Skip to search formSkip to main contentSkip to account menu

azilsartan medoxomil

Known as: (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4- oxadiazol-3-yl)biphenyl-2-yl)methyl)-1H-benzo(d)imidazole-7-carboxylate, Azilsartan medoxomilo, Azilsartanum medoxomilum 
A medoxomil prodrug of azilsartan, an angiotensin II receptor antagonist with antihypertensive activity. Upon hydrolysis, azilsartan selectively and… 
National Institutes of Health

Related topics

Related topics

8 relations
Angiotensin 2 Type 1 Receptor Antagonists [MoA]Azilsartan kamedoxomilDecreased Blood Pressure [PE]

Broader (3)

BenzimidazolesOxadiazolesazilsartan

Narrower (2)

EdarbiTAK-491

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AT1 receptor blocker azilsartan medoxomil normalizes plasma miR-146a and miR-342-3p in a murine heart failure model
Abstract Our study measured circulating microRNA (miRNA) levels in the plasma of calsequestrin (CSQ)-tg mouse, a severe heart… 
2017
2017
Comparison of long‐term safety of fixed‐dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide
This 52‐week, randomized, open‐label study evaluated long‐term safety/tolerability of fixed‐dose combination azilsartan medoxomil… 
2015
2015
UV SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF AZILSARTAN MEDOXOMIL IN BULK AND PHARMACEUTICAL FORMULATIONS
In this study, a simple, sensitive and highly accurate ultraviolet spectrophotometry method has been developed and validated for… 
2015
2015
НОВЫЕ ВОЗМОЖНОСТИ В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ
Despite the great efforts made to effectively control hypertension, achieving target values of blood pressure (BP) can possible… 
2013
2013
Development and Validation of RP-HPLC Method for Azilsartan Medoxomil Potassium Quantitation in Human Plasma by Solid Phase Extraction Procedure
Simple and rapid reverse phase high-performance liquid chromatography (RP-HPLC) method was developed and validated using solid… 
2013
2013
New Simple UV Spectrophotometric Method for Determination of Azilsartan medoxomil in Bulk and Pharmaceutical dosage forms
Azilsartan is an angiotensin II receptor antagonist used in the treatement of hypertension. U.S. Food and Drug Administration(FDA… 
Review
2013
Review
2013
Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?
Introduction: Azilsartan medoxomil is the newest angiotensin receptor blocker marketed for the treatment of arterial hypertension… 
Review
2013
Review
2013
Azilsartan Medoxomil/Chlorthalidone: A New Fixed-Dose Combination Antihypertensive
OBJECTIVE To evaluate the efficacy, safety, and clinical utility of the combination product azilsartan medoxomil/chlorthalidone… 
2011
2011
The Angiotensin Receptor Blocker, Azilsartan Medoxomil (TAK-491), Suppresses Vascular Wall Expression of Plasminogen Activator Inhibitor Type-I Protein Potentially Facilitating the Stabilization of…
Increased expression of plasminogen activator inhibitor type-I (PAI-1) in vessel walls seems to accelerate atherosclerosis… 
2010
2010
ANTIHYPERTENSIVE EFFICACY OF THE NOVEL ANGIOTENSIN RECEPTOR BLOCKER AZILSARTAN MEDOXOMIL IN COMBINATION WITH AMLODIPINE: PP.16.99
Objective: The combination of amlodipine (AML) with renin-angiotensin blockers is efficacious and well tolerated. We compared the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)